Ordinarie bolagsstämma och extra bolagsstämma...
Ordinarie bolagsstämma och extra bolagsstämma i Oriflame Cosmetics
S.A. ("Bolaget") avhölls idag i Luxemburg. Alla styrelseledamöter
(Lennart Björk, Magnus Brännström, Marie Ehrling, Lilian Fossum,
Alexander af Jochnick, Jonas af Jochnick, Robert af Jochnick, Helle
Kruse Nielsen och Christian Salamon) omvaldes för tiden intill slutet
av nästkommande ordinarie bolagsstämma. Robert af Jochnick omvaldes
till styrelsens ordförande för tiden intill slutet av nästkommande
ordinarie bolagsstämma. KPMG S.à . r.l. omvaldes till Bolagets
revisor.
Ordinarie bolagsstämma godkände styrelsens beslut om en utdelning på
EUR 1,25 per aktie (eller motsvarande summa i SEK per svenskt
depåbevis). Sista dag för handel i Oriflameaktien inklusive rätt till
utdelning är den 19 maj 2008. Utbetalning beräknas ske genom VPC AB
den 27 maj 2008.
Den extra bolagsstämman godkände styrelsens förslag om ett nytt
aktieincitamentsprogram i enlighet med kallelsen till den ordinarie
och extra bolagsstämman.
Alla övriga förslag till beslut presenterade vid ordinarie och extra
bolagsstämma i enlighet med kallelsen godkändes av aktieägarna.
Pressmeddelandet kan även laddas ner från medföljande länk:
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.